Form 4: Director Manuel Hidalgo Medina Exercises GH Stock Units

Director Manuel Hidalgo Medina acquired 232 shares of Guardant Health, Inc. common stock through the vesting of restricted stock units.

Summary

• Director Manuel Hidalgo Medina acquired 232 shares of Guardant Health, Inc. (GH) common stock on May 17, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs) granted on July 17, 2024.
• Following this transaction, the director holds a total of 1,889 shares of common stock directly.
• The remaining balance of unvested restricted stock units held by the director is 6,033.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative action regarding director compensation rather than a strategic or financial shift.

Positives

• The transaction reflects the standard vesting schedule of equity compensation for company leadership.
• The director maintains a direct ownership stake in the company.

Negatives

• None identified; this is a routine equity compensation event.

Risks

• None identified; this is a routine equity compensation event.

Future Outlook

The remaining 6,033 restricted stock units are subject to a monthly vesting schedule over the next three years as per the original grant terms.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice in the biotechnology sector, signaling alignment between leadership and shareholder interests without indicating a change in market sentiment.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard practices for publicly traded biotech firms.
• Director ownership levels are typical for non-executive board members in the precision oncology space.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Continued monthly vesting of the remaining 6,033 restricted stock units.

Key Dates

Keywords

Guardant Health, GH, Form 4, Insider Trading, Equity Compensation, Director Ownership